Evidence map›Paper›PMID 35236549›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2022

Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study.

Ronald Gavidia, Galit Levi Dunietz, Louise M O'Brien, Sonja G Schütz, Matthew E Spector, Paul L Swiecicki, Ronald D Chervin

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Sleep Quality in Head and Neck Cancer.Current oncology (Toronto, Ont.) · 2024
    Observational
  3. Prevalence of obstructive sleep apnea after treatment for advanced T-stage head and neck cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ronald GavidiaDepartment of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor, Michigan.
Galit Levi DunietzDepartment of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor, Michigan.
Louise M O'BrienDepartment of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor, Michigan.
Sonja G SchützDepartment of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor, Michigan.
Matthew E SpectorDepartment of Otolaryngology and Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.
Paul L SwiecickiDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
Ronald D ChervinDepartment of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor, Michigan.
University of Michigan–Ann Arbor · US

Funding

TRAINING IN CLINICAL AND BASIC NEUROSCIENCET32NS007222 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Henry L Paulson · 1985 to 2026
$8.0M
NINDS NIH HHS T32 NS007222
6 · The paper itself

Abstract

STUDY

objectivesHead and neck squamous cell carcinoma (HNSCC) or its treatment may be associated with an increased risk of obstructive sleep apnea (OSA). However, reported relationships between OSA risk factors and HNSCC are inconsistent. This study examined associations between tumor variables and risk of OSA at least 1 year after completion of treatment for HNSCC.

methodsThis cross-sectional study included HNSCC patients of a large academic medical center. Inclusion criteria were age ≥ 18 years, cancer free for at least 1 year, and absence of tracheostomy or mental impairment. The STOP-BANG questionnaire, with a threshold ≥ 3, was used to classify HNSCC patients into elevated and low OSA risk. Tumor characteristics and treatment types were obtained from medical records. Descriptive statistics were used to compare characteristics between OSA risk groups. Unadjusted and age-adjusted logistic and linear regression models were used to explore associations between exposures and OSA risk.

resultsAmong 67 participants, 85% were males, mean age was 62.0 years (8.0 standard deviation), mean body mass index was 28.7 kg/m

conclusionsElevated OSA risk was common after HNSCC treatment. However, measured HNSCC characteristics generally were not different between elevated and low OSA risk groups. Given the high frequency of OSA that appears likely to exist in HNSCC patients, clinicians should inquire about OSA features in patients with a history of HNSCC. CITATION: Gavidia R, Dunietz GL, O'Brien LM, et al. Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study.

Indexed as

Head and Neck NeoplasmsSleep Apnea, ObstructiveAdolescentCross-Sectional StudiesFemaleHumansMaleMiddle AgedSquamous Cell Carcinoma of Head and NeckSurveys and Questionnairescancer treatmenthead and neck squamous cell carcinomaobstructive sleep apneatumor locationtumor stage

Identifiers

PMID35236549
PMCPMC9163620
OpenAlexW4214945358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.